Novartis | NOVN - Marktkapitalisierung

Aktienkurs
120.84
Täglich Wechseln
-0.40 -0.33%
Monatlich
-3.44%
Jährlich
24.67%
Q1 Prognose
120.17




Marktkapitalisierung Veränderung Datum
AbbVie USD 403.83B 5.2B 2025-12
Alcon AG USD 32.44B 1.36B 2026-03
Almirall EUR 2.66B 102.29M 2026-03
Amgen USD 176.25B 24.32B 2025-12
AstraZeneca USD 288.15B 55.08B 2025-12
Autolus Therapeutics Ltd USD 433.81M 0 2026-03
Bayer EUR 36.89B 535.42M 2026-03
Biogen USD 25.82B 5.28B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Fresenius EUR 28.24B 653.36M 2026-03
Fresenius Medical Care EUR 11.68B 275.81M 2026-03
Galapagos EUR 1.89B 49.73M 2026-03
Genmab DKK 80.88B 7.82B 2025-06
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
GRIFOLS EUR 4.43B 3.06B 2026-03
Hikma Pharmaceutical USD 2.92B 1.72B 2026-03
J&J USD 500.24B 67.44B 2025-12
Lonza CHF 39.68B 980.61M 2025-06
Merck EUR 47.3B 6B 2026-03
Merck USD 261.26B 51.62B 2025-12
Novartis USD 265.66B 9.48B 2025-09
Novartis USD 246.07B 11.81B 2025-09
Novo Nordisk A/S DKK 1.45T 86.62B 2025-12
Orion EUR 8.94B 243.74M 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Philips EUR 22.38B 192.58M 2025-12
Recordati EUR 10.15B 660.84M 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
UCB EUR 32.47B 4.91B 2025-06